# Safety/Efficacy Trial of Killed Leishmania Vaccine in Volunteers With no Response to Leishmanin

> **NCT00429715** · PHASE2,PHASE3 · COMPLETED · sponsor: **Tehran University of Medical Sciences** · enrollment: 150 (estimated)

## Conditions studied

- Healthy

## Interventions

- **BIOLOGICAL:** Alum-ALM + BCG
- **BIOLOGICAL:** Alum-ALM + BCG
- **BIOLOGICAL:** Alum-ALM + BCG

## Key facts

- **NCT ID:** NCT00429715
- **Lead sponsor:** Tehran University of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-01
- **Primary completion:** 2007-05
- **Final completion:** 2007-12
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2011-02-17

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00429715

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00429715, "Safety/Efficacy Trial of Killed Leishmania Vaccine in Volunteers With no Response to Leishmanin". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00429715. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*